The Untappable Surge: U.S. Cell and Gene Therapy CDMO Market Poised for $9.5 Billion Breakthrough by 2032

The U.S. Cell and Gene Therapy CDMO Market is driving a revolution in personalized medicine, projected to skyrocket from $2.41 billion in 2024 to $9.53 billion by 2032, exhibiting a robust 17.50% CAGR. This explosive growth is fueled by critical fact...